International researchers led by the Hudson Institute of Medical Research have developed a computational metabolite exchange scoring system to identify and understand the interaction between gut microbes. This could potentially offer therapeutic approaches for a range of diseases, including inflammatory bowel disease and cancer. The team is also collaborating with biotechnology firm BiomeBank to develop new ways to treat and prevent disease by restoring gut microbial ecology.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
